Pluri Subsidiary Coffeesai and Instituto del Caf de Chiapas Announce Strategic Collaboration to Advance Cell-Based Coffee Manufacturing in Mexico
October 08, 2025 09:00 ET Â | Source: Pluri Inc. State-backed collaboration outlines…
Epsilogen Announces the Appointment of Cristina Oliva, MD, PhD as Chief Medical Officer
Board-certified oncologist who brings over 20 years of senior clinical development experience…
Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety Data
Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety…
Spyre Therapeutics Announces Poster Presentations at United European Gastroenterology Week (UEGW) 2025
October 05, 2025 09:00 ET Â | Source: Spyre Therapeutics, Inc. WALTHAM, Mass.,…
Hinge Bio Announces License and Collaboration with Kyorin Pharmaceutical Co., Ltd. for the Development and Commercialization of HB2198 in Japan for Autoimmune Diseases
Hinge Bio to receive $10 million upfront and is eligible to receive…
Rosen Law Firm Urges Jasper Therapeutics, Inc. (NASDAQ: JSPR) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces…
NanoNewron Awarded $2.5 Million in NIH STTR Phase 2 Grant to Advance its Innovative NN-840 Alzheimers Disease Program
The $2.5 Million in NIH STTR Phase 2 Grant allows NanoNewron to…
Vaxart Granted Extension by Nasdaq to Regain Compliance
August 29, 2025 08:00 ET Â | Source: Vaxart, Inc. - Company must…
Eupraxia Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
Announced first patient dosed in the Phase 2b placebo-controlled portion of the…
Caliber Enters 25th Year of Empowering Global Pharma with GxP Digital Solutions
HYDERABAD, India, Aug. 11, 2025 /PRNewswire/ -- Caliber, a leading global provider…
